Danaher Diagnostics

Last update: 20 days ago

Biotechnology
United States (USA) Its 4 main executives

Recent executive movements at Danaher

Thomas Joyce, President, Chief Executive Officer & Director, will retire on Sep. 1, 2020  (news posted on May 7 2020).
Rainer Blair who is Executive Vice President, Life Sciences Businesses, will be promoted to Chief Executive Officer on Sep. 1, 2020  (news posted on May 7 2020).
Pardis Sabeti has joined the company as Director  (news posted on November 14 2019).

Click here to view some more movements at Danaher

Create an alert
to follow the executive moves at Danaher Diagnostics.

Latest M&A news in Biotechnology.

Servier Pharmaceuticals has acquired Symphogen (posted on Jun 5, 2020).
Alexion Pharmaceuticals has announced the acquisition of Portola Pharmaceuticals (posted on May 11, 2020).
Thermo Fisher Scientific has announced the acquisition of Qiagen (posted on Mar 5, 2020).

Latest news about Danaher Diagnostics

Danaher Diagnostics on Wikipedia, Google News & Yahoo Finance

Danaher Diagnostics on LinkedIn, Twitter & YouTube

Danaher Diagnostics has 1,388 competitors including Aptuit (United States (USA)), Callitas Therapeutics (Canada) and Galapagos (Belgium). Danaher Diagnostics is owned by Danaher.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.